ProPhase Labs (PRPH) Reports Q3 EPS of $0.01
Tweet
Share
E-mailGet Alerts PRPH Hot Sheet
Join SI Premium – FREE
ProPhase Labs (NASDAQ: PRPH) reported Q3 EPS of $0.01, versus $0.04 reported last year. Revenue for the quarter came in at $5.2 million, versus $4.4 million reported last year.
For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
- Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
